Effect of a COL1A1 Sp1 binding site polymorphism on arterial pulse wave velocity -: An index of compliance

被引:35
作者
Brull, DJ [1 ]
Murray, LJ
Boreham, CA
Ralston, SH
Montgomery, HE
Gallagher, AM
McGuigan, FEA
Smith, GD
Savage, M
Humphries, SE
Young, IS
机构
[1] Rayne Inst, Royal Free & UCL Med Sch, Dept Med, Div Cardiovasc Genet, London WC1E 6JJ, England
[2] Queens Univ Belfast, Dept Epidemiol & Publ Hlth, Belfast, Antrim, North Ireland
[3] Queens Univ Belfast, Dept Child Hlth, Belfast BT7 1NN, Antrim, North Ireland
[4] Queens Univ Belfast, Dept Clin Chem, Belfast, Antrim, North Ireland
[5] Univ Ulster, Dept Sport & Exercise, Ulster, North Ireland
[6] Univ Ulster, Sch Biomed Sci, Ulster, North Ireland
[7] Univ Aberdeen, Sch Med, Dept Med, Aberdeen AB9 2ZD, Scotland
[8] Univ Aberdeen, Sch Med, Dept Therapeut, Aberdeen AB9 2ZD, Scotland
[9] Univ Bristol, Dept Social Med, Bristol, Avon, England
关键词
compliance; genetics; polymorphism; hypertension;
D O I
10.1161/01.HYP.38.3.444
中图分类号
R6 [外科学];
学科分类号
1002 ; 100210 ;
摘要
Reduced arterial compliance precedes changes in blood pressure, which may be mediated through alterations in vessel wall matrix composition. We investigated the effect of the colla gen type I-alpha1 gene (COL1A1) +2046G>T polymorphism on arterial compliance in healthy individuals. We recruited 489 subjects (251 men and 238 women; mean age, 22.6 +/-1.6 years). COL1A1 genotypes were determined using polymerase chain reaction and digestion by restriction enzyme Ball. Arterial pulse wave velocities were measured in 3 segments, aortoiliac (PWVA), aortoradial (PWVB), and aorto-dorsalis-pedis (PWVF), as an index of compliance using a noninvasive optical method. Data were available for 455 subjects. The sample was in Hardy-Weinberg equilibrium with genotype distributions and allele frequencies that were not significantly different from those reported previously. The T allele frequency was 0.22 (95% confidence interval, 0.19 to 0.24). Two hundred eighty-three (62.2%) subjects were genotype GG, 148 (35.5%) subjects were genotype GT, and 24 (5.3%) subjects were genotype TT. A comparison of GG homozygotes with GT and TT individuals demonstrated a statistically significant association with arterial compliance: PWVF 4.92 +/-0.03 versus 5.06 +/-0.05 m/s (ANOVA, P=0.009), PWVB 4.20 +/-0.03 versus 4.32 +/-0.04 m/s (ANOVA, P=0.036), and PWVA 3.07 +/-0.03 versus 3.15 +/-0.03 m/s (ANOVA, P=0.045). The effects of genotype were independent of age, gender, smoking, mean arterial pressure, body mass index, family history of hypertension, and activity scores. We report an association between the COL1A1 gene polymorphism and arterial compliance. Alterations in arterial collagen type 1A deposition may play a role in the regulation of arterial compliance.
引用
收藏
页码:444 / 448
页数:5
相关论文
共 44 条
  • [1] Lifestyle and hypertension
    Beilin, LJ
    Puddey, IB
    Burke, V
    [J]. AMERICAN JOURNAL OF HYPERTENSION, 1999, 12 (09) : 934 - 945
  • [2] INFLUENCE OF ANGIOTENSIN-II TYPE-1 RECEPTOR POLYMORPHISM ON AORTIC STIFFNESS IN NEVER-TREATED HYPERTENSIVE PATIENTS
    BENETOS, A
    TOPOUCHIAN, J
    RICARD, S
    GAUTIER, S
    BONNARDEAUX, A
    ASMAR, R
    POIRIER, O
    SOUBRIER, F
    SAFAR, M
    CAMBIEN, F
    [J]. HYPERTENSION, 1995, 26 (01) : 44 - 47
  • [3] Large artery stiffness in hypertension
    Benetos, A
    Laurent, S
    Asmar, RG
    Lacolley, P
    [J]. JOURNAL OF HYPERTENSION, 1997, 15 : S89 - S97
  • [4] Influence of angiotensin-converting enzyme and angiotensin II type 1 receptor gene polymorphisms on aortic stiffness in normotensive and hypertensive patients
    Benetos, A
    Gautier, S
    Ricard, S
    Topouchian, J
    Asmar, R
    Poirier, O
    Larosa, E
    Guize, L
    Safar, M
    Soubrier, F
    Cambien, F
    [J]. CIRCULATION, 1996, 94 (04) : 698 - 703
  • [5] Boreham C, 1999, PUBLIC HEALTH, V113, P7, DOI 10.1016/S0033-3506(99)00106-7
  • [6] Physical activity, sports participation, and risk factors in adolescents
    Boreham, CA
    Twisk, J
    Savage, MJ
    Cran, GW
    Strain, JJ
    [J]. MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 1997, 29 (06) : 788 - 793
  • [7] Cameron J D, 1996, J Cardiovasc Risk, V3, P495, DOI 10.1097/00043798-199612000-00003
  • [8] Christen Alejandra I., 1997, Medical Progress Through Technology, V21, P5
  • [9] DEAN V, 1998, BONE, P23
  • [10] *EUR COUNC COMM EX, 1995, EUROFIT EUROFIT MAN, P51